| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Incorporated (LGNYZ) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 8 sells.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 43.8K | $1.9K | -5,000 | |
| Dir | 42.6K | $1.8K | - | |
| Dir | 31.6K | $1.3K | - | |
| Dir | 8.9K | $379.53 | - | |
| Dir | 7.4K | $316.29 | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Sabba Stephen L | Director | Sale+OE | 2,145 | $254.00 | $544,830.00 | -6.0% | |
| Jun 1, 2026 | Reardon Andrew | CLO &Secretary | Sale+OE | 5,000 | $227.06 | $1,135,315.57 | -1.6% |